Delivery Order SPE2DB24D3013-SPE2DB25FFLWS

Award Date 5/20/25
Potential Completion Date 5/21/25
Potential Value $1.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,943.34, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4564572082 - DEXAMETHASONE 0.5 MG/5 ML ELX 237ML, a pharmaceutical product. The contract has an ultimate completion date of May 13, 2024 and is a firm fixed-price delivery order. There is no set-aside designation mentioned in the award information provided....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of dexamethasone 0.5 mg/5 ml elixir, a pharmaceutical product. The contract has a ceiling value of $8,299.60 and a performance period ending on April 28, 2025. The contract is a firm fixed-price, non-set-aside delivery order. Amerisourcebergen Drug Corp is the prime contractor and this award is part of a larger...
This is a federal contract award by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price of $1,105.10 for the supply of DEXAMETHASONE 2 MG TABLET 100S. The award does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,083.94, is for the delivery of DEXAMETHASONE 20 MG/5 ML VIAL 5ML, a medical product. This is a firm fixed-price Delivery Order contract with an ultimate completion date of June 11, 2024. The contract is not designated with a set-aside. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $6,969.35 firm fixed-price contract is for the supply of 4558476695 DEXAMETHASONE 20 MG/5 ML VIAL 5ML, with a completion date of September 16, 2022. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This federal contract award is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the supply of Dexamethasone 0.5 mg/5 ml Elixir, a pharmaceutical product, with a ceiling value of $1,792.29 and a period of performance through March 14, 2024. The contract is a firm fixed price arrangement...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of parent company Cencora, Inc. The contract is for the delivery of 4560373921 - Dexamethasone 20 mg/5 ml vial, 5 ml, a pharmaceutical product. The contract is a firm fixed-price delivery order with a ceiling value of $5,751.75 and a completion date of March 27, 2023. This contract was awarded on an unrestricted, full and open competition basis, with no set-aside...
This is a delivery order awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,565,911,624 units of Dexamethasone 20 mg/5 ml vials, a critical medication. The order has a firm fixed price of $5,562.90 and a completion date of September 24, 2024. Amerisourcebergen, through its extensive pharmaceutical supply chain, will provide this medication to support various military treatment...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, under an Indefinite Delivery Contract (IDC) valued at $999,999,999. The order is for DEXAMETHASONE 6 MG TABLET UD 100S, with a ceiling value of $2,709. The contract has a firm fixed price and is set to be completed by January 10, 2024. There is no set-aside designation for this award. AmerisourceBergen, as the prime contractor, will be responsible for...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,182.24, is for the delivery of 4,566,189,769 milliliters of dexamethasone 10 mg/mL vials. The contract is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of October 25, 2024. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
  • SPE2DB24D3013
    Indefinite Delivery Contract
  • SPE2DB24D3013-SPE2DB25FFLWS
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DEXAMETHASONE 0.5 MG/5 ML ELX 237ML, a pharmaceutical product, with a ceiling value of $1,939.02 and a period of performance through May 21, 2025. The contract is a firm fixed price, non-set-aside award, indicating open competition.

Amerisourcebergen Drug Corp is a for-profit organization that serves as a critical supplier of medical and pharmaceutical products to federal agencies, particularly the DLA. The company holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order contract is likely part of the company's broader support of military and veteran healthcare systems through the DLA IDC.

Generated 8/24/25, 1:02 AM